IDEXX LABORATORIES INC /DE Cash and Restricted Cash
IDEXX LABORATORIES INC /DE (IDXX) had Cash and Restricted Cash of $196.93 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-04
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $196.93M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $200.53M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $180.07M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $208.17M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $196.93M 10-Q · filed 2026-08-04 |
| 2026-03-31 | $200.53M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $180.07M 10-Q · filed 2026-08-04 |
| 2025-09-30 | $208.17M 10-Q · filed 2025-11-03 |
| 2025-06-30 | $164.59M 10-Q · filed 2026-08-04 |
| 2025-03-31 | $163.97M 10-Q · filed 2026-05-05 |
| 2024-12-31 | $288.27M 10-Q · filed 2026-08-04 |
| 2024-09-30 | $308.64M 10-Q · filed 2025-11-03 |
| 2024-06-30 | $401.59M 10-Q · filed 2025-08-04 |
| 2024-03-31 | $397.43M 10-Q · filed 2025-05-01 |
| 2023-12-31 | $453.93M 10-K · filed 2026-02-20 |
| 2023-09-30 | $331.70M 10-Q · filed 2024-10-31 |
| 2023-06-30 | $132.84M 10-Q · filed 2024-08-06 |
| 2023-03-31 | $111.37M 10-Q · filed 2024-05-01 |
| 2022-12-31 | $112.55M 10-K · filed 2026-02-20 |
| 2022-09-30 | $99.18M 10-Q · filed 2023-11-01 |
| 2022-06-30 | $114.36M 10-Q · filed 2023-08-01 |
| 2022-03-31 | $204.62M 10-Q · filed 2023-05-02 |
| 2021-12-31 | $144.45M 10-K · filed 2025-02-21 |
| 2021-09-30 | $145.20M 10-Q · filed 2022-11-01 |
| 2021-06-30 | $232.13M 10-Q · filed 2022-08-02 |
| 2021-03-31 | $351.16M 10-Q · filed 2022-05-04 |
| 2020-12-31 | $383.93M 10-K · filed 2024-02-22 |
| 2020-09-30 | $175.59M 10-Q · filed 2021-11-02 |
| 2020-06-30 | $105.29M 10-Q · filed 2021-07-30 |
| 2020-03-31 | $81.39M 10-Q · filed 2021-05-04 |
| 2019-12-31 | $90.33M 10-K · filed 2023-02-16 |
| 2019-09-30 | $104.00M 10-Q · filed 2020-10-29 |
| 2019-06-30 | $110.84M 10-Q · filed 2020-07-31 |
| 2019-03-31 | $116.62M 10-Q · filed 2020-04-30 |
| 2018-12-31 | $123.79M 10-K · filed 2022-02-16 |
| 2018-09-30 | $146.88M 10-Q · filed 2019-10-31 |
| 2018-06-30 | $174.56M 10-Q · filed 2019-08-01 |
| 2018-03-31 | $159.23M 10-Q · filed 2019-05-01 |
| 2017-12-31 | $187.68M 10-K · filed 2021-02-12 |
| 2017-09-30 | $169.02M 10-Q · filed 2018-11-01 |
| 2017-06-30 | $165.97M 10-Q · filed 2018-08-01 |
| 2017-03-31 | $160.41M 10-Q · filed 2018-05-04 |
| 2016-12-31 | $154.90M 10-K · filed 2020-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |